Silvana Morello
Impact in
- Physiology top 0.2%
- Adenosine and Purinergic Signaling
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
Papers in
- Physiology 34
- Adenosine and Purinergic Signaling 34
- Immunology 28
- Immune cells in cancer 7
- Immune Cell Function and Interaction 7
- Immune Response and Inflammation 6
- Immunotherapy and Immune Responses 5
- Co-authors
- Aldo Pinto (24 shared papers)Rosalinda Sorrentino (19 shared papers)Lucio Miele (7 shared papers)Piera Maiolino (7 shared papers)Carla Cicala (17 shared papers)Claudia Sorrentino (8 shared papers)Raffaella Iannone (4 shared papers)Aldo Pinto (11 shared papers)
- Journals
- The Journal of Immunology (4 papers)Journal of Cellular Physiology (4 papers)European Journal of Pharmacology (3 papers)Life Sciences (3 papers)OncoImmunology (3 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Silvana Morello
73 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 109
- Physiology 745
- Immunology 724
- Oncology 533
- Cancer Research 176
- Molecular Biology 671
Countries citing papers authored by Silvana Morello
This map shows the geographic impact of Silvana Morello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Morello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Morello more than expected).
Fields of papers citing papers by Silvana Morello
This network shows the impact of papers produced by Silvana Morello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Morello. The network helps show where Silvana Morello may publish in the future.
Co-authors
The 25 scholars most cited alongside Silvana Morello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 125 | |
| 2 | Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model. | 2014 | 114 |
| 3 | 2015 | 98 | |
| 4 | 2005 | 89 | |
| 5 | 2018 | 79 | |
| 6 | 2017 | 79 | |
| 7 | 2012 | 76 | |
| 8 | 2006 | 69 | |
| 9 | 2011 | 62 | |
| 10 | 2011 | 61 | |
| 11 | 2022 | 60 | |
| 12 | 2019 | 60 | |
| 13 | 2015 | 59 | |
| 14 | 2005 | 51 | |
| 15 | 2008 | 48 | |
| 16 | 2003 | 48 | |
| 17 | 2009 | 47 | |
| 18 | 2012 | 47 | |
| 19 | 2010 | 46 | |
| 20 | 2013 | 46 |
About Silvana Morello
Silvana Morello is a scholar working on Physiology, Immunology, Molecular Biology, Oncology and Cellular and Molecular Neuroscience, having authored 74 papers that have together received 2.3k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (34 papers), Immune cells in cancer (7 papers), Peptidase Inhibition and Analysis (7 papers), Immune Cell Function and Interaction (7 papers), Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Advanced Drug Delivery Systems (4 papers). The work is most often cited by research in Physiology (745 citations), Immunology (724 citations), Oncology (533 citations), Cancer Research (176 citations) and Molecular Biology (671 citations). Silvana Morello has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Aldo Pinto, Rosalinda Sorrentino, Lucio Miele, Piera Maiolino, Carla Cicala, Claudia Sorrentino, Raffaella Iannone, Aldo Pinto, Amalia Porta and Ian M. Adcock. Their work appears in journals such as The Journal of Immunology, Journal of Cellular Physiology, European Journal of Pharmacology, Life Sciences and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.